Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Bosch Schips M"'
Autor:
Bosch-Schips M; Hematology Department, Hospital Universitari Vall d'Hebron, Experimental Hematology, Vall d'Hebron Institute of Oncology (VHIO), Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain., Artaza G; Hematology Department, Hospital Universitari Vall d'Hebron, Experimental Hematology, Vall d'Hebron Institute of Oncology (VHIO), Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain., Hernández-Mata C; Hematology Department, Hospital Universitari Vall d'Hebron, Experimental Hematology, Vall d'Hebron Institute of Oncology (VHIO), Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain., Pérez Beltrán V; Pediatric Nephrology Department, Hospital Universitari Vall d'Hebron, Barcelona, Spain., Cabello Ruiz V; Pediatric Nutrition and Gastroenterology Department, Hospital Universitari Vall d'Hebron, Barcelona, Spain., Olivera Sumire P; Hematology Department, Hospital Universitari Vall d'Hebron, Experimental Hematology, Vall d'Hebron Institute of Oncology (VHIO), Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain.
Publikováno v:
Frontiers in pediatrics [Front Pediatr] 2024 Apr 03; Vol. 12, pp. 1385065. Date of Electronic Publication: 2024 Apr 03 (Print Publication: 2024).
Autor:
Benítez-Hidalgo O; Servei d'Hematologia, Experimental Hematology, Vall d'Hebron Institute of Oncology (VHIO), Vall d'Hebron Barcelona Hospital Campus, Vall d'Hebron Hospital Universitari, Barcelona, Spain.; Departament de Medicina, Universitat Autònoma de Barcelona, Bellaterra, Spain., Bosch Schips M; Servei d'Hematologia, Experimental Hematology, Vall d'Hebron Institute of Oncology (VHIO), Vall d'Hebron Barcelona Hospital Campus, Vall d'Hebron Hospital Universitari, Barcelona, Spain.; Departament de Medicina, Universitat Autònoma de Barcelona, Bellaterra, Spain., Juárez Giménez JC; Pharmacy Department, Vall d'Hebron University Hospital, Barcelona, Spain., Gironella M; Servei d'Hematologia, Experimental Hematology, Vall d'Hebron Institute of Oncology (VHIO), Vall d'Hebron Barcelona Hospital Campus, Vall d'Hebron Hospital Universitari, Barcelona, Spain.; Departament de Medicina, Universitat Autònoma de Barcelona, Bellaterra, Spain.
Publikováno v:
Hematology (Amsterdam, Netherlands) [Hematology] 2023 Dec; Vol. 28 (1), pp. 2242656.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Bosch-Schips M; Hospital Universitari Vall d'Hebron., Navarrete M; Hospital Universitari Vall d'Hebron.
Publikováno v:
Blood [Blood] 2023 Aug 31; Vol. 142 (9), pp. 856.
Autor:
Mirallas O; Medical Oncology Department, Vall d'Hebron Hospital Campus and Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain., Bosch-Schips M; Hematology Department, Vall d'Hebron Hospital Campus and Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain., Pardo N; Medical Oncology Department, Vall d'Hebron Hospital Campus and Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain., Aubanell A; Radiology Department, Vall d'Hebron Hospital Campus, Barcelona, Spain., Salcedo-Allende MT; Pathology Department, Vall d'Hebron Hospital Campus, Barcelona, Spain., Callejo A; Medical Oncology Department, Vall d'Hebron Hospital Campus and Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain., Iranzo P; Medical Oncology Department, Vall d'Hebron Hospital Campus and Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain., Tabernero J; Medical Oncology Department, Vall d'Hebron Hospital Campus and Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain., Felip E; Medical Oncology Department, Vall d'Hebron Hospital Campus and Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain.
Publikováno v:
Frontiers in oncology [Front Oncol] 2022 Mar 30; Vol. 12, pp. 837630. Date of Electronic Publication: 2022 Mar 30 (Print Publication: 2022).
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Publikováno v:
Haemophilia. Feb2022 Supplement S1, Vol. 28, p127-134. 8p.
Autor:
Thieblemont C; Assistance Publique & Hôpitaux de Paris (APHP), Hôpital Saint-Louis, Hémato-oncologie, Université de Paris, Paris, France. catherine.thieblemont@aphp.fr., Karimi YH; Division of Hematology/Oncology, University of Michigan, Ann Arbor, MI, USA., Ghesquieres H; Hospices Civils de Lyon, Centre Hospitalier Lyon Sud, Pierre-Bénite, France., Cheah CY; Sir Charles Gairdner Hospital and the University of Western Australia, Nedlands, Australia., Clausen MR; Vejle Hospital, Vejle, Denmark., Cunningham D; The Royal Marsden NHS Foundation Trust, Sutton, UK., Jurczak W; MSC National Research Institute of Oncology, Kraków, Poland., Do YR; Keimyung University Dongsan Medical Center, Daegu, Republic of Korea., Gasiorowski R; Concord Hospital, University of Sydney, Sydney, Australia., Lewis DJ; University Hospitals Plymouth NHS Trust, Derriford Hospital, Plymouth, UK., Kim TM; Seoul National University Hospital, Seoul, Republic of Korea., van der Poel M; Lunenburg Lymphoma Phase I/II Consortium-HOVON/LLPC, Maastricht, Department of Internal Medicine, Division of Hematology, GROW School for Oncology and Developmental Biology, Maastricht University Medical Center, Maastricht, The Netherlands., Poon ML; National University Hospital, Singapore, Singapore., Feldman T; John Theurer Cancer Center at Hackensack Meridian Health, Hackensack Meridian Health School of Medicine, Hackensack, NJ, USA., Linton KM; The Christie NHS Foundation Trust, Manchester Cancer Research Centre, and Division of Cancer Sciences, University of Manchester, Manchester, UK., Sureda A; Clinical Hematology Department, Institut Català d'Oncologia - L'Hospitalet, IDIBELL, Universitat de Barcelona, Barcelona, Spain., Hutchings M; Rigshospitalet and University of Copenhagen, Copenhagen, Denmark., Dinh MH; AbbVie, North Chicago, IL, USA., Kilavuz N; Genmab, Plainsboro, NJ, USA., Soong D; Genmab, Plainsboro, NJ, USA., Mark T; Genmab, Copenhagen, Denmark., Sacchi M; Genmab, Plainsboro, NJ, USA., Phillips T; University of Michigan Comprehensive Cancer Center, Ann Arbor, MI, USA.; City of Hope, Duarte, CA, USA., Lugtenburg PJ; Lunenburg Lymphoma Phase I/II Consortium-HOVON/LLPC, Erasmus MC Cancer Institute, Department of Hematology, University Medical Center, Rotterdam, The Netherlands.
Publikováno v:
Leukemia [Leukemia] 2024 Dec; Vol. 38 (12), pp. 2653-2662. Date of Electronic Publication: 2024 Sep 25.
Autor:
Kyvsgaard ER; Department of Hematology, Rigshospitalet, Copenhagen, Denmark.; Phase 1 Unit, Rigshospitalet, Copenhagen, Denmark.; Biotech Research and Innovation Center (BRIC), University of Copenhagen, Copenhagen, Denmark., Riley C; Department of Hematology, Rigshospitalet, Copenhagen, Denmark.; Phase 1 Unit, Rigshospitalet, Copenhagen, Denmark., Clausen MR; Department of Hematology, Vejle University Hospital, Vejle, Denmark., Harsløf M; Department of Hematology, Rigshospitalet, Copenhagen, Denmark.; Phase 1 Unit, Rigshospitalet, Copenhagen, Denmark., Heftdal LD; Viro-immunology Research Unit, Department of Infectious Diseases, Copenhagen University Hospital Rigshospitalet, Copenhagen, Denmark., Niemann CU; Department of Hematology, Rigshospitalet, Copenhagen, Denmark., Grønbaek K; Department of Hematology, Rigshospitalet, Copenhagen, Denmark.; Phase 1 Unit, Rigshospitalet, Copenhagen, Denmark., Hutchings M; Department of Hematology, Rigshospitalet, Copenhagen, Denmark.; Phase 1 Unit, Rigshospitalet, Copenhagen, Denmark., Husby S; Department of Hematology, Rigshospitalet, Copenhagen, Denmark.; Phase 1 Unit, Rigshospitalet, Copenhagen, Denmark.; Biotech Research and Innovation Center (BRIC), University of Copenhagen, Copenhagen, Denmark.
Publikováno v:
British journal of haematology [Br J Haematol] 2024 Jan; Vol. 204 (1), pp. 356-360. Date of Electronic Publication: 2023 Oct 13.
Autor:
Oriol Mirallas, Marc Bosch-Schips, Nuria Pardo, Anton Aubanell, Maria Teresa Salcedo-Allende, Ana Callejo, Patricia Iranzo, Josep Tabernero, Enriqueta Felip
Publikováno v:
Scientia
Metastatic hepatic rupture; Non-small cell lung carcinoma; Tyrosine kinase inhibitor Ruptura hepática metastásica; Carcinoma de pulmón de células no pequeñas; Inhibidor de la tirosina quinasa Ruptura hepàtica metastàtica; Carcinoma de pulmó d
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::12effaf284a4dd804af516ae6f0a6da6
https://hdl.handle.net/11351/8026
https://hdl.handle.net/11351/8026
